Pharmaceutical Executive

The Weight-Loss Gold Rush: Legal and Regulatory Implications

Listen Later
Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses:
  • Top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs
  • How the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs
  • What needs to be done for GLP-1s to be covered
  • Steps companies developing weight-loss medications should take to ensure responsible and ethical practice
  • Advice for investors and financiers who are considering entering the weight-loss medication market
    • ...more
    View all episodesView all episodes
    Download on the App Store
    Pharmaceutical ExecutiveBy Pharmaceutical Executive Podcast
    • 4.9
    • 4.9
    • 4.9
    • 4.9
    • 4.9

    4.9

    14 ratings

    More shows like Pharmaceutical Executive

    View all
    Planet Money by NPR

    Planet Money

    30,609 Listeners

    Economist Podcasts by The Economist

    Economist Podcasts

    4,225 Listeners

    Motley Fool Money by The Motley Fool

    Motley Fool Money

    3,228 Listeners

    WSJ Your Money Briefing by The Wall Street Journal

    WSJ Your Money Briefing

    1,713 Listeners

    WSJ What’s News by The Wall Street Journal

    WSJ What’s News

    4,420 Listeners

    Bloomberg Businessweek by Bloomberg

    Bloomberg Businessweek

    427 Listeners

    WSJ Tech News Briefing by The Wall Street Journal

    WSJ Tech News Briefing

    1,649 Listeners

    HBR IdeaCast by Harvard Business Review

    HBR IdeaCast

    154 Listeners

    Bold Names by The Wall Street Journal

    Bold Names

    1,448 Listeners

    The Indicator from Planet Money by NPR

    The Indicator from Planet Money

    9,556 Listeners

    The Readout Loud by STAT

    The Readout Loud

    337 Listeners

    Thoughts on the Market by Morgan Stanley

    Thoughts on the Market

    1,320 Listeners

    The Journal. by The Wall Street Journal & Spotify Studios

    The Journal.

    6,097 Listeners

    Bloomberg Daybreak: US Edition by Bloomberg

    Bloomberg Daybreak: US Edition

    87 Listeners

    WSJ's Take On the Week by The Wall Street Journal

    WSJ's Take On the Week

    150 Listeners